Peripheral nerve function and symptom distress during biotherapy for malignant melanoma.

作者: Constance G. Visovsky

DOI: 10.5737/1181912X153161167

关键词:

摘要: Studies of biotherapy-induced physiological changes are few, and systematic monitoring for neurotoxic effects lacking. The purpose this exploratory pilot study was to determine the change in peripheral nerve function symptom distress during treatment with biotherapy malignant melanoma. A convenience sample 11 participants melanoma receiving interferon-alpha had measures measured at baseline, four 12 weeks treatment. Data were analyzed using plots regression slopes over time sensation, gait/balance, vision, hearing, vibratory sense, muscle strength, deep tendon reflexes, blood pressure, distress. Declines vibration, strength found. Changes visual acuity, orthostatic pressure noted, while gait/balance remained stable. Additionally, neuropathy symptoms associated characterization such can increase our understanding nature high-dose aid clinicians better prepare patients anticipated subsequent lifestyle adjustments. These findings be used provide information a larger phenomenon regarding important outcomes measurement time-points therapy-induced decreasing cancer biologic agents.

参考文章(25)
D M Miltenburg, The validity of tuning fork tests in diagnosing hearing loss. Journal of Otolaryngology. ,vol. 23, pp. 254- 259 ,(1994)
B F Andreassi, G E Gotaskie, Paclitaxel: a new antimitotic chemotherapeutic agent. Cancer Practice. ,vol. 2, pp. 27- 33 ,(1994)
T.J. Postma, K. Hoekman, J.M.G.H. van Riel, J.J. Heimans, J.B. Vermorken, Peripheral Neuropathy Due to Biweekly Paclitaxel, Epirubicin and Cisplatin in Patients with Advanced Ovarian Cancer Journal of Neuro-oncology. ,vol. 45, pp. 241- 246 ,(1999) , 10.1023/A:1006343818656
M S Rendell, J J Katims, R Richter, F Rowland, A comparison of nerve conduction velocities and current perception thresholds as correlates of clinical severity of diabetic sensory neuropathy. Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 52, pp. 502- 511 ,(1989) , 10.1136/JNNP.52.4.502
Verna A. Rhodes, Roxanne W. McDaniel, Sherri Simms Homan, Mary Johnson, Richard Madsen, An instrument to measure symptom experience. Symptom occurrence and symptom distress. Cancer Nursing. ,vol. 23, pp. 49- 54 ,(2000) , 10.1097/00002820-200002000-00008
T. Berger, R. Malayer, A. Doppelbauer, G. Krajnik, H. Huber, E. Auff, R. Pirker, Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy European Journal of Cancer. ,vol. 33, pp. 1393- 1399 ,(1997) , 10.1016/S0959-8049(97)00103-2
A. Quattrini, Giancarlo Comi, Raffaello Nemni, Vittorio Martinelli, Antonello Villa, Marco Caimi, Lawrence Wrabetz, Nicola Canal, Axonal neuropathy associated with interferon-α treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells Acta Neuropathologica. ,vol. 94, pp. 504- 508 ,(1997) , 10.1007/S004010050740
Emanuel K. Manesis, Constantin Petrou, Demetrios Brouzas, Stephanos Hadziyannis, Optic tract neuropathy complicating low-dose interferon treatment Journal of Hepatology. ,vol. 21, pp. 474- 477 ,(1994) , 10.1016/S0168-8278(05)80331-9